Latest / The BioHub - by Avetix
Episode 167 - James Mackay - Co-Founder, President & CEO of Crystalys Therapeutics
Today’s guest is James Mackay, Chief Executive Officer of Crystalys — a biotech company tackling one of the most common yet often overlooked metabolic diseases: gout.
James brings decades of experience across the biotechnology and pharmaceutical industries, including senior leadership roles and a track record of helping bring innovative therapies to market. His career spans global pharma and emerging biotech, where he’s built a reputation for translating cutting-edge science into real-world treatments.
At Crystalys, James is leading the development of novel therapies designed to address gout…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.